BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8968692)

  • 21. No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.
    Roelofzen JH; Aben KK; Oldenhof UT; Coenraads PJ; Alkemade HA; van de Kerkhof PC; van der Valk PG; Kiemeney LA
    J Invest Dermatol; 2010 Apr; 130(4):953-61. PubMed ID: 20016499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
    Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
    Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A carcinogenic bioassay of certain roofing materials.
    Emmett EA; Bingham EM; Barkley W
    Am J Ind Med; 1981; 2(1):59-64. PubMed ID: 7349035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compensating lung cancer patients occupationally exposed to coal tar pitch volatiles.
    Armstrong B; Thériault G
    Occup Environ Med; 1996 Mar; 53(3):160-7. PubMed ID: 8704856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study on the carcinogenic effect of common coal tar and of a new synthetic tar].
    Hilfrich J; Mohr U
    Arch Dermatol Forsch; 1972; 242(2):176-8. PubMed ID: 5024626
    [No Abstract]   [Full Text] [Related]  

  • 26. Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar.
    Godschalk RW; Ostertag JU; Moonen EJ; Neumann HA; Kleinjans JC; van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):767-73. PubMed ID: 9752984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The carcinogenic effect of Locacorten tar oil under experimental conditions].
    Linnik AB
    Vestn Dermatol Venerol; 1970 Dec; 44(12):32-6. PubMed ID: 5516663
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
    Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA
    Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer risk estimation for mixtures of coal tars and benzo(a)pyrene.
    Gaylor DW; Culp SJ; Goldstein LS; Beland FA
    Risk Anal; 2000 Feb; 20(1):81-5. PubMed ID: 10795341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent binding of components of coal-tar, creosote and bitumen to the DNA of the skin and lungs of mice following topical application.
    Schoket B; Hewer A; Grover PL; Phillips DH
    Carcinogenesis; 1988 Jul; 9(7):1253-8. PubMed ID: 3383342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of skin cancers in patients with atopic dermatitis treated with ocal tar. A 25-year follow-up study.
    Maughan WZ; Muller SA; Perry HO; Pittelkow MR; O'Brien PC
    J Am Acad Dermatol; 1980 Dec; 3(6):612-5. PubMed ID: 7204678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should coal tar products carry cancer warnings?
    Zackheim HS
    Cutis; 2004 May; 73(5):333-4. PubMed ID: 15186048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption of polycyclic aromatic hydrocarbons through human skin: differences between anatomical sites and individuals.
    VanRooij JG; De Roos JH; Bodelier-Bade MM; Jongeneelen FJ
    J Toxicol Environ Health; 1993 Apr; 38(4):355-68. PubMed ID: 8478978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The carcinogenicity and mutagenicity of therapeutic coal tar--a perspective.
    Bickers DR
    J Invest Dermatol; 1981 Aug; 77(2):173-4. PubMed ID: 7276611
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
    Clonfero E; Jongeneelen F; Zordan M; Levis AG
    IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PAHs exposure and occupational health risk assessment of workers in coal tar pitch factory].
    Lu CD; Sun XC; Zhang LS; Zhang F
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Jan; 36(1):38-41. PubMed ID: 29495178
    [No Abstract]   [Full Text] [Related]  

  • 37. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benzo(a)pyrene and the carcinogenic effect of coal tar].
    Turusov VS; Kosoĭ KKh; Parfenov IuD
    Vopr Onkol; 1987; 33(10):62-7. PubMed ID: 3686910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health effects of coal mining and combustion: carcinogens and cofactors.
    Falk HL; Jurgelski W
    Environ Health Perspect; 1979 Dec; 33():203-26. PubMed ID: 540618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To BaP or not to BaP? That is the question.
    Goldstein LS
    Environ Health Perspect; 2001 Aug; 109(8):A356-7. PubMed ID: 11564626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.